NACDS president and CEO Steven Anderson praised endorsement letters the U.S. Chamber of Commerce has written to Congress, noting that they are an indication that the damaging Medicaid prescription drug reimbursement rule is a top-tier issue that requires a Congressional response.
NACDS president and CEO Steven Anderson praised endorsement letters the U.S. Chamber of Commerce has written to Congress, noting that they are an indication that the damaging Medicaid prescription drug reimbursement rule is a top-tier issue that requires a Congressional response. R. Bruce Josten, executive VP of government affairs for the U.S. Chamber of Commerce, sent letters on Aug. 17 to Senate Finance Committee chairman Max Baucus (D, Mont.), Rep. Nancy Boyda (D, Kan.), and Rep. Jo Ann Emerson (R, Mo.) to support their legislation in the Senate and House of Representatives, S.1951 and H.R. 3140, respectively. Both bills would provide a solution to the CMS rule related to the Deficit Reduction Act.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.